Skip to search formSkip to main contentSkip to account menu

0.6 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]

Known as: 0.6 ML Lovenox 100 MG/ML Prefilled Syringe, 0.6 ML ENX sodium 100 MG/ML Prefilled Syringe [Lovenox], ENOXAPARIN SODIUM 60 mg in 0.6 mL SUBCUTANEOUS INJECTION [Lovenox] 
National Institutes of Health

Related topics

Related topics

6 relations
0.8 ML Enoxaparin sodium 100 MG/ML Prefilled Syringe [Lovenox]EnoxaparinEnoxaparin sodiumLovenox

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Neue Aspekte zur Therapie der venösen Thromboembolie
New Therapy-Aspects of Venous Thromboembolism. Low-molecular-weight heparins given once or twice daily subcutaneously without… 
2017
2017
Premier cas de pustulose exanthématique aiguë généralisée (PEAG) induite par l’énoxaparine
2016
2016
Comparability of âÂÂEnoxamedâ a Tunisian Generic Enoxaparin with theOriginator Product: Non-clinical and Clinical Studies
Enoxaparin is a complex, biologically derived low-molecular-weight heparin. The manufacturing process for biologics is complex… 
2015
2015
Generic and Branded Enoxaparin Bioequivalence: A Clinical andExperimental Study
Our aim is to compare a new generic version of enoxaparin (Enoxa®) with the parent brand (Lovenox®). We included patients with… 
2012
2012
Spotlight on Enoxaparin in ST-Segment Elevation Myocardial Infarction
Enoxaparin (enoxaparin sodium; Lovenox®) is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA… 
2010
2010
Comparison of Seven Generic Enoxaparins with Lovenox® on In Vitro Cross-Reactivity with Antibodies From Heparin Induced Thrombocytopenia.
Abstract Abstract 1105 Introduction: Heparin induced thrombocytopenia (HIT) is the major complication of heparin treatment but is… 
2010
2010
Adjonction d’antithrombotiques in situ en cas de replantation digitale : étude prospective préliminaire de 13 cas
2009
2009
énoxaparine sodique: Anticoagulant : héparine de bas poids moléculaire (HBPM) – Lovenox®
2004
2004
Neue Aspekte zur Therapie der venösen Thromboembolie
New Therapy-Aspects of Venous Thromboembolism. Low-molecular-weight heparins given once or twice daily subcutaneously without… 
1995
1995
Histologische Veränderungen in den unterbundenen Stümpfen der Ovarialgefässe bei präoperativer niedermolekularer Heparinprophylaxe
Fragestellung: WAhrend einer Adnexektomie untersuchten wir thrombotische VerAnderungen sowie GefAsslAsionen und resezierten die… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)